Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

392 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Folate Receptor as a Biomarker and Therapeutic Target in Solid Tumors.
Young O, Ngo N, Lin L, Stanbery L, Creeden JF, Hamouda D, Nemunaitis J. Young O, et al. Among authors: nemunaitis j. Curr Probl Cancer. 2023 Feb;47(1):100917. doi: 10.1016/j.currproblcancer.2022.100917. Epub 2022 Nov 17. Curr Probl Cancer. 2023. PMID: 36508886 Free article. Review.
Systemic benefit of radiation therapy via abscopal effect.
Craig DJ, Ambrose S, Stanbery L, Walter A, Nemunaitis J. Craig DJ, et al. Among authors: nemunaitis j. Front Oncol. 2022 Oct 25;12:987142. doi: 10.3389/fonc.2022.987142. eCollection 2022. Front Oncol. 2022. PMID: 36387120 Free PMC article.
Corrigendum to "Gemogenovatucel-T (Vigil) immunotherapy demonstrates clinical benefit in homologous recombination proficient (HRP) ovarian cancer" [Gynecologic Oncology Volume 161, Issue 3, June 2021, Pages 676-680].
Rocconi RP, Monk BJ, Walter A, Herzog TJ, Galanis E, Manning L, Bognar E, Wallraven G, Stanbery L, Aaron P, Senzer N, Coleman RL, Nemunaitis J. Rocconi RP, et al. Among authors: nemunaitis j. Gynecol Oncol. 2023 Feb;169:173. doi: 10.1016/j.ygyno.2022.11.010. Epub 2022 Nov 28. Gynecol Oncol. 2023. PMID: 36456375 No abstract available.
NF-κB Signaling in Tumor Pathways Focusing on Breast and Ovarian Cancer.
Devanaboyina M, Kaur J, Whiteley E, Lin L, Einloth K, Morand S, Stanbery L, Hamouda D, Nemunaitis J. Devanaboyina M, et al. Among authors: nemunaitis j. Oncol Rev. 2022 Oct 3;16:10568. doi: 10.3389/or.2022.10568. eCollection 2022. Oncol Rev. 2022. PMID: 36531159 Free PMC article. Review.
Advances in Targeted Therapy for the Treatment of Cervical Cancer.
Watkins DE, Craig DJ, Vellani SD, Hegazi A, Fredrickson KJ, Walter A, Stanbery L, Nemunaitis J. Watkins DE, et al. Among authors: nemunaitis j. J Clin Med. 2023 Sep 15;12(18):5992. doi: 10.3390/jcm12185992. J Clin Med. 2023. PMID: 37762931 Free PMC article. Review.
Smart exosomes enhance PDAC targeted therapy.
Creeden JF, Sevier J, Zhang JT, Lapitsky Y, Brunicardi FC, Jin G, Nemunaitis J, Liu JY, Kalinoski A, Rao D, Liu SH. Creeden JF, et al. Among authors: nemunaitis j. J Control Release. 2024 Apr;368:413-429. doi: 10.1016/j.jconrel.2024.02.037. Epub 2024 Mar 7. J Control Release. 2024. PMID: 38431093 Free article.
Regulatory role of CD39 and CD73 in tumor immunity.
Kaplinsky N, Williams K, Watkins D, Adams M, Stanbery L, Nemunaitis J. Kaplinsky N, et al. Among authors: nemunaitis j. Future Oncol. 2024 Apr 23. doi: 10.2217/fon-2023-0871. Online ahead of print. Future Oncol. 2024. PMID: 38652041 Free article. Review.
392 results